JANUET 50/850 MG TABLETS
Land: Israel
Språk: engelsk
Kilde: Ministry of Health
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG
Tilgjengelig fra:
MERCK SHARP & DOHME ISRAEL LTD
ATC-kode:
A10BA02
Legemiddelform:
TABLETS
Administreringsrute:
PER OS
Produsert av:
MERCK SHARP & DOHME CORP., USA
Terapeutisk gruppe:
METFORMIN
Indikasjoner:
Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.
Autorisasjon dato:
2009-01-01
